跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XEPAGAN ELIXIR 10 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
XEPAGAN ELIXIR 10 MG/5 ML
Approved
THERAPEUTIC
XEPAGAN ELIXIR 10 MG/5 ML
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 7, 1989
Approval ID
6680c4cda274b1ec
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
6680c4cda274b1ec
Drug Name
XEPAGAN ELIXIR 10 MG/5 ML
Product Name
XEPAGAN ELIXIR 10 MG/5 ML
Approval Number
SIN03294P
Approval Date
1989-06-07
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
ELIXIR
Route Of Administration
ORAL
Atc Code
R06AD02
Atc Item Name
promethazine
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
PROMETHAZINE HCl
10 mg/5 ml
PROMETHAZINE HCL
10 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 7, 1989
Approval ID
6680c4cda274b1ec
Type
Therapeutic
Back to HSA Approvals